Literature DB >> 32286628

Machine learning predicts new anti-CRISPR proteins.

Simon Eitzinger1, Amina Asif2,3, Kyle E Watters1, Anthony T Iavarone4, Gavin J Knott1, Jennifer A Doudna1,5,6,7,8,9, Fayyaz Ul Amir Afsar Minhas2,10.   

Abstract

The increasing use of CRISPR-Cas9 in medicine, agriculture, and synthetic biology has accelerated the drive to discover new CRISPR-Cas inhibitors as potential mechanisms of control for gene editing applications. Many anti-CRISPRs have been found that inhibit the CRISPR-Cas adaptive immune system. However, comparing all currently known anti-CRISPRs does not reveal a shared set of properties for facile bioinformatic identification of new anti-CRISPR families. Here, we describe AcRanker, a machine learning based method to aid direct identification of new potential anti-CRISPRs using only protein sequence information. Using a training set of known anti-CRISPRs, we built a model based on XGBoost ranking. We then applied AcRanker to predict candidate anti-CRISPRs from predicted prophage regions within self-targeting bacterial genomes and discovered two previously unknown anti-CRISPRs: AcrllA20 (ML1) and AcrIIA21 (ML8). We show that AcrIIA20 strongly inhibits Streptococcus iniae Cas9 (SinCas9) and weakly inhibits Streptococcus pyogenes Cas9 (SpyCas9). We also show that AcrIIA21 inhibits SpyCas9, Streptococcus aureus Cas9 (SauCas9) and SinCas9 with low potency. The addition of AcRanker to the anti-CRISPR discovery toolkit allows researchers to directly rank potential anti-CRISPR candidate genes for increased speed in testing and validation of new anti-CRISPRs. A web server implementation for AcRanker is available online at http://acranker.pythonanywhere.com/.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 32286628      PMCID: PMC7229843          DOI: 10.1093/nar/gkaa219

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  61 in total

1.  Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.

Authors:  Benjamin J Rauch; Melanie R Silvis; Judd F Hultquist; Christopher S Waters; Michael J McGregor; Nevan J Krogan; Joseph Bondy-Denomy
Journal:  Cell       Date:  2016-12-29       Impact factor: 41.582

Review 2.  CRISPR/Cas, the immune system of bacteria and archaea.

Authors:  Philippe Horvath; Rodolphe Barrangou
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

Review 3.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

4.  Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.

Authors:  Heng Zhang; Zhuang Li; Courtney M Daczkowski; Clinton Gabel; Andrew D Mesecar; Leifu Chang
Journal:  Cell Host Microbe       Date:  2019-05-30       Impact factor: 21.023

Review 5.  CRISPR/Cas9 for genome editing: progress, implications and challenges.

Authors:  Feng Zhang; Yan Wen; Xiong Guo
Journal:  Hum Mol Genet       Date:  2014-03-20       Impact factor: 6.150

Review 6.  Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.

Authors:  Gary E Heussler; George A O'Toole
Journal:  J Bacteriol       Date:  2016-04-28       Impact factor: 3.490

7.  Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.

Authors:  Bianca Garcia; Jooyoung Lee; Alireza Edraki; Yurima Hidalgo-Reyes; Steven Erwood; Aamir Mir; Chantel N Trost; Uri Seroussi; Sabrina Y Stanley; Ronald D Cohn; Julie M Claycomb; Erik J Sontheimer; Karen L Maxwell; Alan R Davidson
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

8.  A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.

Authors:  April Pawluk; Joseph Bondy-Denomy; Vivian H W Cheung; Karen L Maxwell; Alan R Davidson
Journal:  mBio       Date:  2014-04-15       Impact factor: 7.867

Review 9.  Phages Fight Back: Inactivation of the CRISPR-Cas Bacterial Immune System by Anti-CRISPR Proteins.

Authors:  Karen L Maxwell
Journal:  PLoS Pathog       Date:  2016-01-07       Impact factor: 6.823

10.  Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.

Authors:  Alexander P Hynes; Geneviève M Rousseau; Daniel Agudelo; Adeline Goulet; Beatrice Amigues; Jeremy Loehr; Dennis A Romero; Christophe Fremaux; Philippe Horvath; Yannick Doyon; Christian Cambillau; Sylvain Moineau
Journal:  Nat Commun       Date:  2018-07-25       Impact factor: 14.919

View more
  21 in total

1.  PaCRISPR: a server for predicting and visualizing anti-CRISPR proteins.

Authors:  Jiawei Wang; Wei Dai; Jiahui Li; Ruopeng Xie; Rhys A Dunstan; Christopher Stubenrauch; Yanju Zhang; Trevor Lithgow
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

2.  Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.

Authors:  Guoxu Song; Fei Zhang; Chunhong Tian; Xing Gao; Xiaoxiao Zhu; Dongdong Fan; Yong Tian
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

3.  Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes.

Authors:  Andrew Varble; Edmondo Campisi; Chad W Euler; Pascal Maguin; Albina Kozlova; Jessica Fyodorova; Jakob T Rostøl; Vincent A Fischetti; Luciano A Marraffini
Journal:  Nat Microbiol       Date:  2021-11-24       Impact factor: 17.745

4.  Crystal structure of the anti-CRISPR, AcrIIC4.

Authors:  Gi Eob Kim; So Yeon Lee; Hyun Ho Park
Journal:  Protein Sci       Date:  2021-10-29       Impact factor: 6.725

5.  Phylogenetic Analysis of Anti-CRISPR and Member Addition in the Families.

Authors:  Sweta Nidhi; Pooja Tripathi; Vijay Tripathi
Journal:  Mol Biotechnol       Date:  2022-09-15       Impact factor: 2.860

6.  A versatile active learning workflow for optimization of genetic and metabolic networks.

Authors:  Amir Pandi; Christoph Diehl; Ali Yazdizadeh Kharrazi; Scott A Scholz; Elizaveta Bobkova; Léon Faure; Maren Nattermann; David Adam; Nils Chapin; Yeganeh Foroughijabbari; Charles Moritz; Nicole Paczia; Niña Socorro Cortina; Jean-Loup Faulon; Tobias J Erb
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

Review 7.  Type II anti-CRISPR proteins as a new tool for synthetic biology.

Authors:  Yadan Zhang; Mario Andrea Marchisio
Journal:  RNA Biol       Date:  2020-10-13       Impact factor: 4.652

Review 8.  Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics.

Authors:  Xiao Tan; Justin H Letendre; James J Collins; Wilson W Wong
Journal:  Cell       Date:  2021-02-10       Impact factor: 41.582

9.  Coalitional Strategies for Efficient Individual Prediction Explanation.

Authors:  Gabriel Ferrettini; Elodie Escriva; Julien Aligon; Jean-Baptiste Excoffier; Chantal Soulé-Dupuy
Journal:  Inf Syst Front       Date:  2021-05-22       Impact factor: 5.261

Review 10.  New Directions in Pulmonary Gene Therapy.

Authors:  Amber Vu; Paul B McCray
Journal:  Hum Gene Ther       Date:  2020-09       Impact factor: 4.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.